Cancer vaccine attenuates carcinogen induced head and neck cancer with impaired early T cell response
Michihisa Kono, Masahiro Rokugo, John D. Quadarella, Shin Saito, Hiroki Komatsuda, Cong Fu, Sook-Bin Woo, Ann Marie Egloff, Ravindra Uppaluri
This study shows that a cancer vaccine combined with anti-PD-1 therapy reduces tumor burden and improves survival in a head and neck cancer model with impaired T cell responses.
bioRxiv · Jun 26, 2024 · PreprintCancer Biology